The Role of the Telehealth Pharmacist: Regulatory Considerations

Activity Preview

Join the APhA-APPM Medication Management Special Interest Group for The Role of the Telehealth Pharmacist: Regulatory Considerations. This program is intended for pharmacists and pharmacy technicians who are interested in providing telehealth services. The goal of this activity is to help participants understand the regulations and legislative environment that impact national and state-level telehealth programs. This is the fourth module in a 4-module series on The Role of the Telehealth Pharmacist.

Learning Objectives

At the completion of this application-based activity, participants will be able to:

  1. Describe the changing telepharmacy regulatory and legislative environment around the United States.
  2. Discuss the differences between how each state implements telepharmacy regulations.
  3. Review the Centers for Medicare & Medicaid regulations specific to telehealth.

Activity type: Knowledge-based

Target Audience: Pharmacists & Pharmacist Technicians

Learning Level: 1

Accreditation Information


The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following activity is approved for 0.5 contact hour of CPE credit (0.05 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-122-H04-P/T.

To obtain credit for completing The Role of the Telehealth Pharmacist: Regulatory Considerations, watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript. 

Initial release date: January 15, 2019
Expiration date: January 15, 2022 


The Role of the Telehealth Pharmacist: Regulatory Considerations is an archived, online educational activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association.


Adam Chestler, PharmD  and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at

Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association. 


There is no fee associated with this activity.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements.